Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Reed

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Journal of the American Geriatrics Society|November 1, 2023
Optimizing delirium care in the era of Age-Friendly Health SystemMin Ji Kwak, Sharon K Inouye, Donna M Fick, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2010
First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC seriesRoshan Agarwal, Charlie Gourley, Timothy J Perren, et al.
Gynecologic Oncology|May 23, 2013
The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: data from CALYPSO trial (a GINECO-GCIG study)Benoit You, Olivier Colomban, Mark Heywood, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2016
A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial CancerPatricia Pautier, Ignace Vergote, Florence Joly, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2010
International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG)Akila N Viswanathan, Carien L Creutzberg, Peter Craighead, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 27, 2021
Longitudinal Blood Pressure Patterns From Mid- to Late Life and Late-Life Hearing Loss in the Atherosclerosis Risk in Communities StudyJames Ting, Kening Jiang, Simo Du, et al.
International Journal of Molecular Sciences|April 30, 2021
Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief OverviewRiccardo Di Fiore, Sherif Suleiman, Francesca Pentimalli, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 20, 2022
The Association Between Midlife Leisure-Time Physical Activity and Hearing Loss in Late Life in the Atherosclerosis Risk in Communities StudyPablo Martinez-Amezcua, Emmanuel Garcia Morales, Kelley P Gabriel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2023
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994Gemma G Kenter, Stefano Greggi, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2011
Training in bowel and upper abdominal surgery in gynaecological oncology: European Society of Gynecological Oncology (ESGO) StatementDavid Cibula, Rene Verheijen, Alberto Lopes, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of the American Geriatrics Society|November 1, 2023
Optimizing delirium care in the era of Age-Friendly Health SystemMin Ji Kwak, Sharon K Inouye, Donna M Fick, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2010
First-line therapy for ovarian cancer with carboplatin followed by paclitaxel-gemcitabine (SCOTROC5): a feasibility study and comparative analysis of the SCOTROC seriesRoshan Agarwal, Charlie Gourley, Timothy J Perren, et al.
Gynecologic Oncology|May 23, 2013
The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: data from CALYPSO trial (a GINECO-GCIG study)Benoit You, Olivier Colomban, Mark Heywood, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 22, 2016
A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial CancerPatricia Pautier, Ignace Vergote, Florence Joly, et al.
International Journal of Radiation Oncology, Biology, Physics|December 25, 2010
International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG)Akila N Viswanathan, Carien L Creutzberg, Peter Craighead, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 27, 2021
Longitudinal Blood Pressure Patterns From Mid- to Late Life and Late-Life Hearing Loss in the Atherosclerosis Risk in Communities StudyJames Ting, Kening Jiang, Simo Du, et al.
International Journal of Molecular Sciences|April 30, 2021
Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief OverviewRiccardo Di Fiore, Sherif Suleiman, Francesca Pentimalli, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|September 20, 2022
The Association Between Midlife Leisure-Time Physical Activity and Hearing Loss in Late Life in the Atherosclerosis Risk in Communities StudyPablo Martinez-Amezcua, Emmanuel Garcia Morales, Kelley P Gabriel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2023
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994Gemma G Kenter, Stefano Greggi, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 2, 2011
Training in bowel and upper abdominal surgery in gynaecological oncology: European Society of Gynecological Oncology (ESGO) StatementDavid Cibula, Rene Verheijen, Alberto Lopes, et al.
Pageof 7